iX Biopharma Ltd. (SGX:42C)
0.1360
+0.0010 (0.74%)
Dec 31, 2025, 12:04 PM SGT
iX Biopharma Market Cap
iX Biopharma has a market cap or net worth of 129.06 million as of December 30, 2025. Its market cap has increased by 461.93% in one year.
Market Cap
129.06M
Enterprise Value
134.02M
Revenue
7.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since July 22, 2015, iX Biopharma's market cap has decreased from 330.51M to 129.06M, a decrease of -60.95%. That is a compound annual growth rate of -8.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 128.10M | 480.08% |
| Dec 31, 2024 | 22.08M | -35.96% |
| Dec 28, 2023 | 34.48M | -65.12% |
| Dec 30, 2022 | 98.85M | -32.86% |
| Dec 31, 2021 | 147.23M | -17.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haw Par Corporation | 3.50B |
| Raffles Medical Group | 1.88B |
| Thomson Medical Group | 1.53B |
| Riverstone Holdings | 1.30B |
| Q & M Dental Group (Singapore) | 495.83M |
| Vicplas International | 49.06M |
| Cordlife Group | 33.83M |